Dietary Fiber: New Findings in Gut Health and Prevention of Metabolic Diseases, Especially Diabetes

Date: June 20
Time: 1 - 2 p.m. (Central time)

Dietary fiber continues to be a nutrient of concern in the US diet with usual intakes only about ½ of recommended levels and only 5% consuming the recommended amount. Novel fibers that can be added to functional beverages & foods have allowed manufacturers to formulate products with fiber blends known to improve gut and metabolic=health. For this webinar we will first update new findings on fiber chemistry, fiber’s impact on gut health via the microbiome, and fiber supplements that can be incorporated into foods and beverages. Additionally, we will present new research on the effects of proprietary fiber blends on gut health, especially the microbiota and their implications on prevention of diabetes.

Sponsored by: Supergut

CPE Level: 2
CPEU: 1
Performance Indicators: 8.1.4, 8.2.1, 8.2.2

Learning Objectives

• Describe novel dietary fibers that improve gut health via the microbiota.
• Identify dietary fiber sources that improve metabolic health via changes in biomarkers associated with diabetes prevention.
• Teach patients strategies to increase dietary fiber intake with fibers known to have physiological benefits.

Speakers

Joanne Slavin, PhD, RDN

Dr. Slavin is a Professor in the Department of Food Science and Nutrition, University of Minnesota – Twin Cities. She has published more than 350 research papers focusing on the effect of dietary fiber on health outcomes. Recent studies have focused on the effects of isolated fibers on satiety, blood glucose, and gut markers including the microbiota and short chain fatty acids. She was a member of the 2010 Dietary Guidelines Advisory Committee (DGAC) and also served as a member of the 2001 Dietary Reference Intakes Proposed Definition of Dietary fiber committee.

Chris Damman, MD, MA

Chris Damman is Chief Medical & Science officer at UR Labs. Prior to joining UR Labs, he lead the Gut Health Initiative at the Bill & Melinda Gates Foundation. He holds an M.D. from Columbia University, an M.A. in Molecular Biology & Biochemistry from Wesleyan University, and is board certified in Gastroenterology. Chris maintains an academic appointment with the University of Washington in the division of gastroenterology with research interests focused on food and microbiome therapeutics for non-communicable disease.